• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,614.13 -114.24
( -0.15%)
Global Indices
Nasdaq
52,219.26 322.15
(0.62%)
Dow Jones
7,463.83 88.81
(1.20%)
Hang Seng
70,280.54 812.43
(1.17%)
Nikkei 225
10,501.14 -6.88
(-0.07%)
Forex
USD-INR
94.12 -0.28
(-0.30%)
EUR-INR
107.15 -0.14
(-0.13%)
GBP-INR
124.16 -0.32
(-0.26%)
JPY-INR
0.58 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Vineet Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543298
INE505Y01010
23.0043581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VINEETLAB
0
64.28
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

jaykay enterprises ltd
Gilada Finance & Investments standalone net profit declines 13.21% in the March 2026 quarter
May 29,2026
Net profit of Gilada Finance & Investments declined 13.21% to Rs 0.46 crore in the quarter ended March 2026 as against Rs 0.53 crore during the previous quarter ended March 2025. Sales rose 5.03% to Rs 1.88 crore in the quarter ended March 2026 as against Rs 1.79 crore during the previous quarter ended March 2025.

For the full year,net profit rose 1.88% to Rs 2.17 crore in the year ended March 2026 as against Rs 2.13 crore during the previous year ended March 2025. Sales rose 7.24% to Rs 7.26 crore in the year ended March 2026 as against Rs 6.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.881.79 5 7.266.77 7
OPM %60.1154.75 -59.0959.23 -
PBDT0.660.80 -18 2.992.95 1
PBT0.640.76 -16 2.932.90 1
NP0.460.53 -13 2.172.13 2